Zobrazeno 1 - 10
of 34
pro vyhledávání: '"stefano spinaci"'
Autor:
Harriet Johansson, Aliana Guerrieri-Gonzaga, Sara Gandini, Bjørn-Erik Bertelsen, Debora Macis, Davide Serrano, Gunnar Mellgren, Matteo Lazzeroni, Parijatham S. Thomas, Katherine D. Crew, Nagi B. Kumar, Irene Maria Briata, Viviana Galimberti, Giuseppe Viale, Lana A. Vornik, Valentina Aristarco, Tania Buttiron Webber, Stefano Spinaci, Powel H. Brown, Brandy M. Heckman-Stoddard, Eva Szabo, Bernardo Bonanni, Andrea DeCensi
Publikováno v:
npj Breast Cancer, Vol 10, Iss 1, Pp 1-8 (2024)
Abstract In a 3-arm presurgical trial, four-six weeks exemestane 25 mg three times/week (TIW) was non-inferior to 25 mg/day (QD) in suppressing circulating estradiol in postmenopausal women with ER-positive breast cancer. Since obesity may decrease e
Externí odkaz:
https://doaj.org/article/d80f769e4684451285f4994baf3c0f8c
Autor:
Giulia Ferrarazzo, Alberto Nieri, Emma Firpo, Andrea Rattaro, Alessandro Mignone, Flavio Guasone, Augusto Manzara, Giuseppe Perniciaro, Stefano Spinaci
Publikováno v:
Current Oncology, Vol 30, Iss 10, Pp 8703-8719 (2023)
Background: In clinically node-positive (cN+) breast cancer (BC) patients who become clinically node-negative (cN0) following neoadjuvant chemotherapy (NACT), sentinel lymph node biopsy (SLNB) after lymphatic mapping with lymphoscintigraphy is not wi
Externí odkaz:
https://doaj.org/article/0f66c7ab75d84f87824088f6e22669f6
Autor:
Enrica Teresa Tanda, Elena Croce, Francesco Spagnolo, Lodovica Zullo, Stefano Spinaci, Carlo Genova, Giovanni Rossi
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Immunotherapy has changed the landscape of treatments for advanced disease in multiple neoplasms. More and more patients are long survivors from a metastatic disease. Most recently, the extension of indications and evidence of efficacy in early disea
Externí odkaz:
https://doaj.org/article/0d1e3f8c6047402fa0fb1f2878be7335
Autor:
Benedetta Bonardi, Claudia Massarotti, Marco Bruzzone, Oranite Goldrat, Giorgia Mangili, Paola Anserini, Stefano Spinaci, Luca Arecco, Lucia Del Mastro, Marcello Ceppi, Isabelle Demeestere, Matteo Lambertini
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Background: The co-administration of letrozole during controlled ovarian stimulation (COS) with gonadotropins is used to limit the potentially harmful effects of a supra-physiological rise in estrogen levels on hormone-sensitive cancers. However, the
Externí odkaz:
https://doaj.org/article/f6ed57eacde54587a72d7599374211f1
Autor:
Luca Arecco, Marta Perachino, Alessandra Damassi, Maria Maddalena Latocca, Davide Soldato, Giacomo Vallome, Francesca Parisi, Maria Grazia Razeti, Cinzia Solinas, Marco Tagliamento, Stefano Spinaci, Claudia Massarotti, Matteo Lambertini
Publikováno v:
Breast Cancer: Basic and Clinical Research, Vol 14 (2020)
The improved prognosis of breast cancer patients makes survivorship issues an area of crucial importance. In this regard, an increased attention is needed toward the development of potential anticancer treatment-related long-term side-effects, includ
Externí odkaz:
https://doaj.org/article/9dec433f82e14d83a08e6f28c1023856
Autor:
Maria G. Razeti, Davide Soldato, Luca Arecco, Alessia Levaggi, Silvia Puglisi, Cinzia Solinas, Elisa Agostinetto, Stefano Spinaci, Laura Lapuchesky, Carlo Genova, Claudia Massarotti, Matteo Lambertini
Publikováno v:
Clinical Breast Cancer. 23:241-248
Publikováno v:
Aesthetic Plastic Surgery. 46:644-654
Massive weight loss (MWL) has a positive impact on the comorbidities associated with obesity but leaves patients with ongoing body issues due to skin excess. Almost all patients present some degree of breast ptosis and breast volume deficiency, which
Autor:
Luca Arecco, Eva Blondeaux, Marco Bruzzone, Marcello Ceppi, Maria Maddalena Latocca, Andrea Boutros, Camilla Marrocco, Maria Grazia Razeti, Maurizio Cosso, Stefano Spinaci, Margherita Condorelli, Claudia Massarotti, Lucia Del Mastro, Isabelle Demeestere, Matteo Lambertini
Publikováno v:
Cancer Research. 82:PD5-07
Background: Controlled ovarian stimulation (COS) for oocyte/embryo cryopreservation before starting chemotherapy is standard of care for young women with breast cancer wishing to preserve fertility. However, some oncologists remain concerned on the s
Autor:
Davide Serrano, Sara Gandini, Parjhitham Thomas, Katherine D. Crew, Nagi B. Kumar, Lana A. Vornik, J. Jack Lee, Paolo Veronesi, Giuseppe Viale, Aliana Guerrieri-Gonzaga, Matteo Lazzeroni, Harriet Johansson, Mauro D’Amico, Flavio Guasone, Stefano Spinaci, Bjørn-Erik Bertelsen, Gunnar Mellgren, Isabelle Bedrosian, Diane Weber, Tawana Castile, Eileen Dimond, Brandy M. Heckman-Stoddard, Eva Szabo, Powel H. Brown, Andrea DeCensi, Bernardo Bonanni
Publikováno v:
JAMA Oncology. 9:664
ImportanceSuccessful therapeutic cancer prevention requires definition of the minimal effective dose. Aromatase inhibitors decrease breast cancer incidence in high-risk women, but use in prevention and compliance in adjuvant settings are hampered by
Autor:
Marta Perachino, Francesca Poggio, Luca Arecco, Eva Blondeaux, Stefano Spinaci, Camilla Marrocco, Alessia Levaggi, Matteo Lambertini
Publikováno v:
Cancer journal (Sudbury, Mass.). 28(3)
Survivorship has become a crucial component in breast cancer care. For women who have not completed their family planning, conceiving at the end of anticancer treatments should not be discouraged but might be challenging. Oncofertility counseling sho